跳到正文

Lycia Therapeutics, Inc.(LYCA)内部人交易:高管与董事近期交易

过去 18 个月,共有 15 位内部人为 Lycia Therapeutics, Inc.(LYCA)报告了 129 笔 Form 4 交易(最近一笔 2026-11-04)。

日期内部人职务类型股数市值
2026-11-04Shah Nimish P10% 以上股东买入8,305$223,820
2026-11-04Koh Bong Y10% 以上股东买入8,305$223,820
2026-11-04Venrock Healthcare Capital Partners III, L.P.10% 以上股东买入8,305$223,820
2026-11-04VHCP Management III, LLC10% 以上股东买入8,305$223,820
2026-11-04VHCP Co-Investment Holdings III, LLC10% 以上股东买入8,305$223,820
2026-11-04Venrock Healthcare Capital Partners EG, L.P.10% 以上股东买入8,305$223,820
2026-11-04VHCP Management EG, LLC10% 以上股东买入8,305$223,820
2026-11-04VHCP Management XP, LLC10% 以上股东买入8,305$223,820
2026-11-04Venrock Healthcare Capital Partners XP, L.P.10% 以上股东买入8,305$223,820
2026-10-30VHCP Management III, LLC10% 以上股东买入10,570$266,681
2026-10-30Shah Nimish P10% 以上股东买入10,570$266,681
2026-10-30Venrock Healthcare Capital Partners III, L.P.10% 以上股东买入10,570$266,681
2026-10-30Koh Bong Y10% 以上股东买入10,570$266,681
2026-10-30VHCP Co-Investment Holdings III, LLC10% 以上股东买入10,570$266,681
2026-10-30Venrock Healthcare Capital Partners EG, L.P.10% 以上股东买入10,570$266,681
2026-10-30VHCP Management EG, LLC10% 以上股东买入10,570$266,681
2026-10-30VHCP Management XP, LLC10% 以上股东买入10,570$266,681
2026-10-30Venrock Healthcare Capital Partners XP, L.P.10% 以上股东买入10,570$266,681
2026-10-30Koh Bong Y10% 以上股东买入4,430$115,047
2026-10-30Shah Nimish P10% 以上股东买入4,430$115,047
2026-10-30Venrock Healthcare Capital Partners III, L.P.10% 以上股东买入4,430$115,047
2026-10-30VHCP Management EG, LLC10% 以上股东买入4,430$115,047
2026-10-30VHCP Co-Investment Holdings III, LLC10% 以上股东买入4,430$115,047
2026-10-30Venrock Healthcare Capital Partners EG, L.P.10% 以上股东买入4,430$115,047
2026-10-30VHCP Management III, LLC10% 以上股东买入4,430$115,047

来源:SEC Form 4 申报文件 · 截至 2026-11-04